T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
TripAdvisor
TRIP
$1.29B
| $210M | 0.05% |
3,336,345
+1,051,790
| +46% | +$79.6M |
|
|
ABCO
402
DELISTED
Advisory Board Co
ABCO
| $210M | 0.05% |
4,605,084
-642,450
| -12% | -$33.4M |
|
403
CME Group
CME
$96.1B
| $209M | 0.05% |
2,255,587
+169,835
| +8% | +$16.1M |
|
404
Zurn Elkay Water Solutions
ZWS
$8.41B
| $208M | 0.05% |
25,430,180
-8,850,980
| -26% | -$88.3M |
|
405
Affiliated Managers Group
AMG
$9.7B
| $208M | 0.05% |
1,214,839
+319,200
| +36% | +$62.8M |
|
406
Fortinet
FTNT
$121B
| $207M | 0.05% |
24,364,425
+386,890
| +2% | +$3.42M |
|
407
Broadcom
AVGO
$1.99T
| $206M | 0.05% |
16,439,100
+179,700
| +1% | +$2.27M |
|
|
FLTX
408
DELISTED
Fleetmatics Group PLC
FLTX
| $205M | 0.05% |
4,178,553
-425,990
| -9% | -$20.3M |
|
|
MON
409
DELISTED
Monsanto Co
MON
| $205M | 0.05% |
2,402,597
-95,486
| -4% | -$9.43M |
|
|
PFPT
410
DELISTED
Proofpoint, Inc.
PFPT
| $204M | 0.05% |
3,387,470
-369,430
| -10% | -$23M |
|
411
Constellation Brands
STZ
$23.3B
| $204M | 0.05% |
1,629,706
+348,024
| +27% | +$42.9M |
|
|
MKTO
412
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $204M | 0.05% |
7,174,509
-87,762
| -1% | -$2.48M |
|
413
Zillow
ZG
$8.15B
| $204M | 0.05% |
7,088,173
-13,582,211
| -66% | -$363M |
|
|
CORE
414
DELISTED
Core Mark Holding Co., Inc.
CORE
| $202M | 0.05% |
6,184,106
+93,480
| +2% | +$2.9M |
|
415
Kimco Realty
KIM
$16.4B
| $201M | 0.04% |
8,238,616
+56,040
| +0.7% | +$1.35M |
|
|
ARG
416
DELISTED
Airgas Inc
ARG
| $199M | 0.04% |
2,229,627
-820,443
| -27% | -$81.3M |
|
417
Lumen
LUMN
$6.6B
| $196M | 0.04% |
7,797,695
-82,670
| -1% | -$2.29M |
|
418
Quest Diagnostics
DGX
$26.1B
| $193M | 0.04% |
3,132,196
+79,430
| +3% | +$5.55M |
|
419
Murphy Oil
MUR
$4.99B
| $192M | 0.04% |
7,914,450
+2,413,200
| +44% | +$77.1M |
|
420
ONE Gas
OGS
$5.09B
| $191M | 0.04% |
4,211,210
+1,563,120
| +59% | +$68.5M |
|
421
Brunswick
BC
$5.29B
| $189M | 0.04% |
3,946,154
-1,297,565
| -25% | -$66M |
|
|
RAX
422
DELISTED
Rackspace Hosting Inc
RAX
| $187M | 0.04% |
7,590,591
-2,912,858
| -28% | -$93.9M |
|
423
Mercado Libre
MELI
$92.7B
| $185M | 0.04% |
2,034,016
+591,321
| +41% | +$69.7M |
|
|
ADPT
424
DELISTED
Adeptus Health Inc
ADPT
| $185M | 0.04% |
2,291,188
+1,115,418
| +95% | +$115M |
|
425
Acadia Pharmaceuticals
ACAD
$4.89B
| $185M | 0.04% |
5,591,664
-40,850
| -0.7% | -$1.7M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.